Full-Time

Senior Manager

Posted on 4/16/2025

Gilead Sciences

Gilead Sciences

10,001+ employees

Develops and commercializes biopharmaceuticals

Compensation Overview

$169.3k - $219.1k/yr

+ Bonus + Stock-based long-term incentives

Senior, Expert

Company Historically Provides H1B Sponsorship

San Mateo, CA, USA

Category
Project Management
Business Development
Business & Strategy
Required Skills
Agile
Development Operations (DevOps)
Requirements
  • Associates Degree and Twelve Years Experience OR Bachelor's Degree and Ten Years’ Experience OR Masters' Degree and Eight Years’ Experience OR PhD and Two Years’ Experience
Responsibilities
  • Advise IT and business leadership on capability enablement opportunities.
  • Develops & maintain roadmaps and backlogs for relevant applications.
  • Partner with business teams to understand their pain points and identify solutions / enhancements to help improve US sales rep effectiveness, efficiency and experience.
  • Engage with product vendors to understand and influence their product release roadmaps to better meet Gilead needs.
  • Develop and maintain Gilead & Kite specific roadmaps for relevant applications managed by the team.
  • Work with the DevOps lead and team to ensure backlog is assigned to appropriate scheduled releases.
  • Leverage existing solutions from the IT toolset and support the business to maximize the benefits delivered from project investment.
  • Partner with product vendors to understand solutions and capabilities to support business needs – leveraging investments made and extending existing solution wherever possible.
  • Ensure that initiatives generated by business functions are in line with the Gilead & Kite Commercial global to local IT regional/global approach and utilize appropriate tools where these already exist within the IT toolset. Global to local mindset to bring about standardization where possible.
  • Projects are planned, managed and monitored to assure benefits are met and potential bottlenecks or failures are identified and addressed in due time.
  • Supports US Capability lead in project planning, scoping & budgeting, assessments, meeting Gilead Unity 3.0 methodology requirements as required.
  • Define, quantify (where feasible) & articulate expected business benefits and other benefits (e.g., compliance) of a proposed investment.
  • Support appropriate selection of solutions and third parties required to support changes identified.
  • Support agile capability delivery wherever feasible to shorten release cycles and deliver business requirements faster.
  • Utilize Agile DevOps to record user stories, features and epics. Lead managed services resources to ensure backlog for each application is managed efficiently and accurately.
  • Ensure availability of appropriate project plans for implementation addressing organizational, technical, process, change management and training perspectives when introducing new applications or sustainment of existing applications.
  • Define & articulate lessons learnt, showcase what good looks like in a project. Build & maintain a repository of best practices over time that can be applied to future projects.
  • Lead a post-project analysis of business & other benefits captured; compare with expected benefits laid out in the business case and address causes for deviations, if any.
  • Enable a conducive working environment for stakeholders, team members and managed services teams.
  • Support a working environment that is conducive to individual growth, high performance, is challenging and rewarding.
  • Undertake personal development activities to ensure that the core tasks and responsibilities of this role continue to be met as the role evolves in line with business, technology, industry and regulatory environment changes.
Desired Qualifications
  • 5-10 years+ experience in a similar role, preferably within the Biotech / Pharmaceutical industry with demonstrated applied IT / Business knowledge in the sales effectiveness domain apart from a general understanding of the pharmaceutical value chain.
  • BS/BA degree in IT, Computer Science or related discipline or equivalent number of years of work experience.
  • Functional knowledge of Veeva CRM, Veeva Events Management, Salesforce platform, Vault platform, Microsoft Power Apps platform, Learning Management Systems.
  • Business degree (e.g. MBA) and/or project management certifications (e.g. PMP, CSM/CSPO, etc.) preferred but not required. Life sciences education / certificate courses preferred but not required.
  • Experience working in a multi-vendor scenario; vendor management experience is a plus.
  • Experience of working through different stages of the systems development life cycle and SLDC methodologies – Agile, Hybrid.
  • Experience working effectively across a matrixed organization and successfully executing and achieving results without direct authority.
  • Experience providing and driving cross-functional and cross-geographical IT solutions to business needs and opportunities.
  • Comfort working directly with both business partners and IT department / solution providers with minimal supervision.
  • High level of personal integrity consistent with Gilead’s core values (Excellence, Accountability, Teamwork, Integrity and Inclusion).

Gilead Sciences is a biopharmaceutical company that develops and sells medicines for various serious health conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company focuses on extensive research and development to create new therapies, which are then approved by regulatory authorities before being marketed to healthcare providers, hospitals, and pharmacies. Gilead stands out from its competitors by investing heavily in R&D and forming strategic partnerships, such as with SAP Ariba, to improve its supply chain and ensure sustainable practices. The company's goal is to enhance health equity and access to care, working with communities globally to remove barriers to healthcare and make its medicines available to those in need.

Company Size

10,001+

Company Stage

IPO

Headquarters

Foster City, California

Founded

1987

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven drug discovery is revolutionizing the biopharmaceutical industry, benefiting companies like Gilead.
  • Gilead's lenacapavir development represents a significant advancement in HIV treatment.
  • Investor confidence in Gilead is strong, as shown by recent investments.

What critics are saying

  • Layoffs at Gilead may disrupt strategic decision-making and operational efficiency.
  • Competition from AI-driven drug discovery companies could outpace traditional methods.
  • STAT6 program partnership with LEO Pharma may face challenges in clinical success.

What makes Gilead Sciences unique

  • Gilead's lenacapavir offers a once-yearly HIV prevention, enhancing patient adherence.
  • Strategic partnership with LEO Pharma expands Gilead's inflammation research portfolio.
  • Gilead's manufacturing efficiencies provide a competitive edge in CAR-T cell therapy production.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Company News

SFist
Apr 2nd, 2025
April Fool's Day Around the Bay: Bob Lee's Family Has Sued His Convicted Killer Nima Momeni

Foster City-based HIV drug company Gilead Sciences is laying off nearly 150 people, and the job cuts are significant among senior members of the company's management.

Labiotech
Mar 27th, 2025
12 Ai Drug Discovery Companies You Should Know About

Newsletter Signup - Under Article / In Page"*" indicates required fields Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the industry now embracing the technology, we take a look at 12 AI drug discovery companies. The COVID-19 pandemic revealed AI to be an essential tool in helping to find treatments and vaccines with greater speed and precision. Since then, there have been several drug discovery breakthroughs for AI within the biopharma industry, from helping to quickly and efficiently discover a new antibiotic called abaucin to combat a multi-drug resistant bacteria, to fully discovering and designing a drug that has entered clinical trials. Here are 12 AI drug discovery companies currently making great strides with their technology. Anima Biotech Technology: mRNA biology modulators Disease areas: Immunology, oncology and neuroscienceRecent news: Announced promising preclinical data for lead pulmonary fibrosis candidate Anima Biotech’s AI drug discovery technology is built around its mRNA Lightning.AI platform, which images hundreds of cellular pathways in both healthy and diseased cells to train disease-specific AI models, making use of neural networks to help these models distinguish between healthy and diseased cells and identify dysregulated pathways. These pathways are subsequently analyzed to uncover novel targets backed by experimental validation. Anima currently has 20 preclinical candidates being evaluated for immunology, oncology, and neuroscience indications, with its most advanced candidate indicated for the treatment of lung fibrosis. The company announced in February 2024 that this candidate had shown promising preclinical results and could open up new avenues for treating patients with idiopathic pulmonary fibrosis. The AI drug discovery company also has ongoing collaborations with several pharma giants. After initially partnering with Eli Lilly in 2018 and Takeda in 2021, its most recent partnership was formed with AbbVie in 2023 for the discovery and development of mRNA biology modulators against oncology and immunology targets. Atomwise Technology: TYK2 inhibitor  Disease area: Autoimmune and autoinflammatory diseasesRecent news: Published results showcasing AtomNet’s ability for drug discoveryAtomwise is leveraging the power of AI in an attempt to revolutionize small molecule drug discovery

Charities.org
Mar 25th, 2025
Sustainability News provided by 3BL

Gilead recently partnered with GRYT Health to host a New Lens on Lung Cancer workshop where people living with lung cancer and their loved ones shared their experience with stigma.

CSR Company
Mar 18th, 2025
Gilead Sciences Ranked in Top Five Most JUST List for Biopharma Companies

Gilead Sciences ranked in top five Most JUST list for biopharma companies.

Pipeline Review
Mar 12th, 2025
First Clinical Data for Gilead's Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

First clinical data for Gilead's investigational Once-Yearly Lenacapavir for HIV Prevention presented at CROI 2025 and published in The Lancet.